doi: 10.1038/s41598-022-25444-3
These conditions not only increase the risk of T2DM but also contribute to cardiovascular disease, cancer, and premature mortality
Weight Loss Medical weight loss programs featuring GLP-1 medications, including compounded Semaglutide and Tirzepatide (where appropriate), as well as FDA-approved brand medications such as Wegovy, Ozempic, Zepbound, and Mounjaro when clinically appropriate and available
Even though sulfur burps werent explicitly monitored in clinical trials, it can be inferred that they could potentially follow the same pattern
Methods and results All randomized, placebo-controlled trials evaluating GLP1-ra and reporting CV outcomes stratified by HF history were searched in Pubmed from inception to November 12th, 2023